Seventh Sense Biosystems
Cambridge, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
HB
HOWARD BERNSTEINExecutive
HW
HOWARD WEISMANExecutive
Board
AC
RL
AS
ANUPENDRA SHARMABoard director
HW
HARRY WILCOXBoard director
PH
PETER HUTTBoard director
RR
R. ROX ANDERSONBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$47.6M disclosed across 8 rounds · 2014–2018
▶$18.5MraisedAug 2018 · 18 investors · BiotechnologyRule 506(b)
▶$18.5MraisedAug 2018 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ROBERT LANGERDirector
- ALAN CRANEDirector
- MARC CEULEMANSDirector
- DONALD HARDISONDirector
- HARRY WILCOXExecutive Officer, Director
- STUART BLITZExecutive Officer
- TIMOTHY RICHARDSExecutive Officer
- HOWARD WEISMANDirector
- PETER HUTTDirector
- Offering amount
- $20.5M
- Amount sold
- $18.5M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.5MraisedFeb 2018 · 15 investors · BiotechnologyRule 506(b)
▶$3.5MraisedFeb 2018 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- HARRY WILCOXDirector
- ALAN CRANEDirector
- DONALD HARDISONDirector
- TIMOTHY RICHARDSExecutive Officer
- HOWARD WEISMANExecutive Officer, Director
- STUART BLITZExecutive Officer
- ROBERT LANGERDirector
- MARC CEULEMANSDirector
- PETER HUTTDirector
- Offering amount
- $5.5M
- Amount sold
- $3.5M
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedSep 2017 · 2 investors · BiotechnologyRule 506(b)
▶$2.5MraisedSep 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- PETER HUTTDirector
- MILAN KOFOLExecutive Officer
- TIMOTHY RICHARDSExecutive Officer
- MARC CEULEMANSDirector
- HOWARD WEISMANExecutive Officer, Director
- DONALD HARDISONDirector
- ALAN CRANEDirector
- STUART BLITZExecutive Officer
- ROBERT LANGERDirector
- HARRY WILCOXDirector
- Offering amount
- $10M
- Amount sold
- $2.5M
- Sales commissions
- $17.5K
- Placement agents
- OUISA CAPITAL LLC
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.5MraisedNov 2016 · 7 investors · BiotechnologyRule 506(b)
▶$5.5MraisedNov 2016 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MILAN KOFOLExecutive Officer
- PETER HUTTDirector
- HOWARD WEISMANExecutive Officer, Director
- ALAN CRANEDirector
- ROBERT LANGERDirector
- HARRY WILCOXDirector
- DONALD HARDISONDirector
- TIMOTHY RICHARDSExecutive Officer
- R. ROX ANDERSONDirector
- Offering amount
- $12.8M
- Amount sold
- $5.5M
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedDec 2015 · 6 investors · BiotechnologyRule 506(b)
▶$2.1MraisedDec 2015 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- HOWARD WEISMANExecutive Officer, Director
- HOWARD BERNSTEINExecutive Officer
- PETER HUTTDirector
- ROBERT LANGERDirector
- R. ROX ANDERSONDirector
- ANUPENDRA SHARMADirector
- HARRY WILCOXDirector
- ALAN CRANEDirector
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14.3MraisedAug 2015 · 8 investors · BiotechnologyRule 506(b)
▶$14.3MraisedAug 2015 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- PETER HUTTDirector
- ALAN CRANEDirector
- ROBERT LANGERDirector
- R. ROX ANDERSONDirector
- HOWARD BERNSTEINExecutive Officer
- ANUPENDRA SHARMADirector
- HOWARD WEISMANExecutive Officer, Director
- HARRY WILCOXDirector
- Offering amount
- $16.3M
- Amount sold
- $14.3M
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$450KraisedJun 2014 · 5 investors · BiotechnologyRule 506(b)
▶$450KraisedJun 2014 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ALAN CRANEDirector
- R. ROX ANDERSONDirector
- ROBERT LANGERDirector
- HARRY WILCOXDirector
- HOWARD WEISMANExecutive Officer, Director
- PETER HUTTDirector
- HOWARD BERNSTEINExecutive Officer
- Offering amount
- $450K
- Amount sold
- $450K
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$930KraisedApr 2014 · 5 investors · BiotechnologyRule 506(b)
▶$930KraisedApr 2014 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- PETER HUTTDirector
- HOWARD BERNSTEINExecutive Officer
- HARRY WILCOXDirector
- HOWARD WEISMANExecutive Officer, Director
- R. ROX ANDERSONDirector
- ALAN CRANEDirector
- ROBERT LANGERDirector
- Offering amount
- $930K
- Amount sold
- $930K
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Seventh Sense Biosystems went on to found or lead other companies.
Frequently asked questions
- Who are Seventh Sense Biosystems's investors?
- Seventh Sense Biosystems's investors include Polaris Partners.
- How much funding has Seventh Sense Biosystems raised?
- Seventh Sense Biosystems has disclosed $47.6M raised across 8 rounds.
- Where is Seventh Sense Biosystems headquartered?
- Seventh Sense Biosystems is headquartered in Cambridge, US.